Found: 7
Select item for more details and to access through your institution.
Advances in medical treatment of esophageal carcinoma: highlights from ESMO congress 2023.
- Published in:
- Journal of Practical Oncology, 2024, v. 39, n. 1, p. 6, doi. 10.13267/j.cnki.syzlzz.2024.002
- By:
- Publication type:
- Article
Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1141420
- By:
- Publication type:
- Article
miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.
- Published in:
- Oncology Letters, 2018, v. 15, n. 4, p. 4619, doi. 10.3892/ol.2018.7861
- By:
- Publication type:
- Article
Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0174276
- By:
- Publication type:
- Article
487. CAMRELIZUMAB COMBINED WITH CHEMOTHERAPY OR APATINIB AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE 2 TRIAL.
- Published in:
- Diseases of the Esophagus, 2023, v. 36, p. 1, doi. 10.1093/dote/doad052.268
- By:
- Publication type:
- Article
Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 7, p. 1905, doi. 10.1111/jcmm.17209
- By:
- Publication type:
- Article
miR‐516a‐3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 9, p. 6295, doi. 10.1111/jcmm.14515
- By:
- Publication type:
- Article